Literature DB >> 15042378

Ocular findings in mitochondrial neurogastrointestinal encephalomyopathy: a case report.

Piero Barboni1, Giacomo Savini, Giuseppe Plazzi, Marzio Bellan, Maria Lucia Valentino, Maurizio Zanini, Pasquale Montagna, Michio Hirano, Valerio Carelli.   

Abstract

PURPOSE: To describe the ocular features of a patient with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) due to a homozygous G1443A mutation in the thymidine-phosphorylase gene.
METHODS: A case report with extensive ophthalmological investigation over a 9-year period, until death at age 38 years. Measures used included standard ophthalmological examination, visual field examination and optical coherence tomography (OCT).
RESULTS: Ptosis and external ophthalmoplegia progressively worsened during the follow-up, as did the neurological and general status. Corneal and optic disc alterations were also observed at the last visit. Glaucomatous changes of the optic disc were confirmed by the visual field examination and OCT.
CONCLUSION: In addition to previously described alterations such as ptosis and external ophthalmoplegia, MNGIE may be associated with glaucomatous-like optic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042378     DOI: 10.1007/s00417-004-0914-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  8 in total

1.  Ophthalmic involvement in myo-neuro-gastrointestinal encephalopathy syndrome.

Authors:  A B Threlkeld; N R Miller; K C Golnik; J W Griffin; R W Kuncl; D R Johns; M Lehar; O Hurko
Journal:  Am J Ophthalmol       Date:  1992-09-15       Impact factor: 5.258

2.  Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome.

Authors:  A Papadimitriou; G P Comi; G M Hadjigeorgiou; A Bordoni; M Sciacco; L Napoli; A Prelle; M Moggio; G Fagiolari; N Bresolin; S Salani; I Anastasopoulos; G Giassakis; R Divari; G Scarlato
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

3.  Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy.

Authors:  M Votruba; D Thiselton; S S Bhattacharya
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

4.  Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations.

Authors:  I Nishino; A Spinazzola; A Papadimitriou; S Hammans; I Steiner; C D Hahn; A M Connolly; A Verloes; J Guimarães; I Maillard; H Hamano; M A Donati; C E Semrad; J A Russell; A L Andreu; G M Hadjigeorgiou; T H Vu; S Tadesse; T G Nygaard; I Nonaka; I Hirano; E Bonilla; L P Rowland; S DiMauro; M Hirano
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

5.  Deficiency of complex II of the mitochondrial respiratory chain in late-onset optic atrophy and ataxia.

Authors:  R W Taylor; M A Birch-Machin; J Schaefer; L Taylor; R Shakir; B A Ackrell; B Cochran; L A Bindoff; M J Jackson; P Griffiths; D M Turnbull
Journal:  Ann Neurol       Date:  1996-02       Impact factor: 10.422

6.  Optic disc excavation in the atrophic stage of Leber's hereditary optic neuropathy: comparison with normal tension glaucoma.

Authors:  Yukihiko Mashima; Itaru Kimura; Yusuke Yamamoto; Hisao Ohde; Yuichirou Ohtake; Tomihiko Tanino; Goji Tomita; Yoshihisa Oguchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-01-25       Impact factor: 3.117

7.  Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency.

Authors:  Yutaka Nishigaki; Ramon Martí; William C Copeland; Michio Hirano
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 8.  Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies.

Authors:  Valerio Carelli; Fred N Ross-Cisneros; Alfredo A Sadun
Journal:  Neurochem Int       Date:  2002-05       Impact factor: 3.921

  8 in total
  4 in total

Review 1.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

Review 2.  Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options.

Authors:  Rana Yadak; Peter Sillevis Smitt; Marike W van Gisbergen; Niek P van Til; Irenaeus F M de Coo
Journal:  Front Cell Neurosci       Date:  2017-02-15       Impact factor: 5.505

Review 3.  Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far.

Authors:  Dario Pacitti; Michelle Levene; Caterina Garone; Niranjanan Nirmalananthan; Bridget E Bax
Journal:  Front Genet       Date:  2018-12-21       Impact factor: 4.599

4.  Clinical spectrum of early onset "Mediterranean" (homozygous p.P131L mutation) mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Sema Kalkan Uçar; Havva Yazıcı; Ebru Canda; Esra Er; Fatma Derya Bulut; Cenk Eraslan; Hüseyin Onay; Bridget Elizabeth Bax; Mahmut Çoker
Journal:  JIMD Rep       Date:  2022-07-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.